Reading the "T" Leaves: Predicting Outcomes with Bispecific Antibodies in Multiple Myeloma
{{output}}
In this issue of Blood Cancer Discovery, Frenking and colleagues demonstrate the prognostic potential of three risk score models to predict hematotoxicity, infections, response rates, and survival following bispecific T-cell engager (TCE) therapy in multiple m... ...
